Sir,
The nice summary article of 'Infantile hypertrophic pyloric stenosis in Belfast, 1957 -1969 ' by J. A Dodge (Archives, 1975 refers in part to jaundice noted in 18% of such patients before operation. In hypothesizing on the subject he fails to mention my favourite thesis, which is that such jaundiced infants have a fairly marked alkalosis and it is this alkalosis which inhibits the activity of the glucuronyl transferase. On occasion there have been infants seen who, on rehydration, clinically seem to clear their jaundice. Unfortunately the definitive study of doing a bilirubin before hydration and correction of alkalosis and then after (but before operation) has not I was interested to read Dr. Cochran's kind comments on my article, and in particular his views on the occurrence of jaundice in infantile pyloric stenosis, and apologize for overlooking the possibility that alkalosis may be a contributory factor.
There is no doubt that correction of metabolic ababnormalities is an important factor in the resolution of jaundice in these babies, but there is no good evidence that it is the restoration of fluid or of acid-base balance which effects the response. Maternal protein depletion in small-for-gestational-age babies Sir, We are interested in the findings of H. Stein (Archives, 1975) as we have a series of unpublished data on work done a few years ago at King Edward VIII Hospital, Durban, South Africa. We were at that time mainly interested in hypoglycaemia in the neonate. In a previous pilot study we found that though the tendency to hypoglycaemia was frequent in the low-birthweight (birthweight < 2 -5 kg) and the small-for-gestational-age infants, the total prevalence of hypoglycaemia was unaccountably high. We are dealing with a population group whose nutritional status is precarious (Powell, 1958; Stein, 1975) . It was thus possible that poor maternal nutrition determined the prevalence of hypoglycaemia and at the same time that of small-for-gestational-age babies.
We studied the possible correlation between maternal serum proteins, neonatal blood glucose levels, and the small-for-gestational-age babies. Group A consisted of 99 newborn babies and their mothers: 27 preterm infants, 27 babies of low birthweight, and 53 small-forgestational-age babies. There was an overlap between categories, some babies being placed in more than one category. (Archives, 1975) . He has principally investigated the contrast in terms of hypoglycaemia and maternal serum protein levels between term infants (group B) and a group of preterm, low-birthweight, and small-for-gestational-age infants (group A). Even in Group A where he contrasts his 3 categories there is only a relatively small percentage of low-birthweight infants (27 out of 99) and it is not clear whether these are preterm or small-for-gestational-age.
We, on the other hand, investigated a group of low-birthweight infants only, but excluded twins, as we had previously shown that these babies contributed significantly to the high incidence of low-birthweight infants seen by us (26%) and especially the small-forgestational-age group (Stein and Ellis, 1974) ; in the present investigation we were looking for additional aetiological factors. Almost all of our cases were preterm (94 out of 103) and the majority were small-forgestational-age.
It appears that the whole emphasis of the investigations was different. It is also not clear whether Dr. Parent excluded twins as we did. Thus while the population groups are similar, the investigations do not appear comparable.
H (Miller and Nilsson, 1974) , C5 alone is not sufficient for complete opsonization of yeast. In other words, a deficiency in the yeast opsonic assay may reflect any one of a number of factors, including C5. In order to establish a diagnosis of C5 dysfunction it is therefore necessary to perform appropriate reconstitution experiments using purified human C5 (Miller and Koblenzer, 1972) . Illustration of this point is provided by the observations that patients with other opsonic defects, as for example the patient of Alper and Rosen (1975) with hypercatabolism of C3, have abnormal yeast opsonic assays.
I agree that the nature of any defect revealed, solely, by abnormal yeast opsonic activity requires further definition. In the family reported by us, however, substantial evidence has been presented which points to a functional defect of the C5 molecule as the cause of the opsonic defect (Nilsson, Miller, and Wyman, 1974) . The altemate pathway of complement in this family is normal.
The importance of studies such as that of Scott and co-workers is re-emphasized. A number of opsonic defects obviously exist and the full characterization of each should be vigorously pursued. Not only do we leam much of the normal inflammatory response from each of these defects, but the promise of specific therapy by improved characterization of each is great.
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